Galician consensus on management of cardiotoxicity in breast cancer: risk factors, prevention, and early intervention
![Thumbnail](/xmlui/themes/Mirage2//images/thumbnails/thumn_cientif.png)
Identificadores![](/xmlui/themes/Mirage2//images/despl_identif.png)
Identificadores
Visualización o descarga de ficheros![](/xmlui/themes/Mirage2//images/despl_contenidos.png)
Visualización o descarga de ficheros
Fecha de publicación
2017-09Título de revista
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico CLINICAL & TRANSLATIONAL ONCOLOGY
Tipo de contenido
Artigo
DeCS
antraciclinas | neoplasias de la mama | farmacoterapia | mamaMeSH
Breast | Drug Therapy | Breast Neoplasms | AnthracyclinesResumen
This Galician consensus statement is a joint oncologists/cardiologists initiative indented to establish basic recommendations on how to prevent and to manage the cardiotoxicity in breast cancer with the aim of ensuring an optimal cardiovascular care of these patients. A clinical screening of the patients before treatment is recommended to stratify them into a determined risk group based on their intrinsic cardiovascular risk factors and those extrinsic arose from breast cancer therapy, thereby providing individualized preventive and monitoring measures. Suitable initial and ongoing assessments for patients with low and moderate/high risk and planned treatment with anthracyclines and trastuzumab are given; also, measures aimed at preventing and correcting any modifiable risk factor are pointed out .
El ítem tiene asociados los siguientes ficheros de licencia:
![](/xmlui/themes/Mirage2//images/final_lines.png)